focus -WSS

focus

author：fashion 2025-08-11 09:49:50 - browse：32

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Diverse clinical trials: Why aren’t we there yet?

WSS

Study says nonprofit hospitals fall short in charity care spending

Food makers to regulators: Ultra

Why the world’s most expensive drug might be worth the price

FDA's naming rule on biosimilars has undermined competition

FDA panel endorses Alnylam’s heart drug — after picking it apart

FDA's naming rule on biosimilars has undermined competition

explore

focus

focus

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Merck, Vertex, and Viking updates

Hepatitis C has a cure — but many Americans still lack access to it

Primary care physicians play key roles in Alzheimer's management

Supreme Court strikes down use of affirmative action

Decaf coffee targeted by food safety group under obscure FDA rule

Malaria cases in Florida and Texas: Here’s what you need to know

New Covid vaccine is recommended for everyone 6 months or older

Wikipedia

Scientists boost immune system in aging mice by making it youthful

New weight loss drugs vying to be the next Wegovy or Mounjaro

Readout LOUD podcast: mifepristone case, GLP

Telehealth for opioid use disorder is lifesaving

Eliminate the waiting period for sterilization covered by Medicaid

New Covid vaccine is recommended for everyone 6 months or older

focus

focus

entertainment

leisure time